About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Techno Medica Co., Ltd.(6678) Financial Results

6678
TSE Standard
Techno Medica Co., Ltd.
1,816
JPY
+19
(+1.06%)
Dec 25, 3:20 pm JST
11.36
USD
Dec 24, 11:23 pm EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2021 9,040 1,607 1,629 1,153 135.8 51 May 12, 2021 J-GAAP
Mar, 2022 9,699 1,861 1,851 1,281 150.9 60 May 11, 2022 J-GAAP
Mar, 2023 9,367 1,649 1,668 1,150 136.4 60 May 10, 2023 J-GAAP
Mar, 2024 10,283 1,840 1,870 1,348 173.0 68 May 9, 2024 J-GAAP
Mar, 2025 Guidance 10,000 1,400 1,400 970 139.9 68 May 9, 2024 J-GAAP
YoY -2.8% -23.9% -25.1% -28.0% -19.1%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 10,283 2,288 2,249 1,429 173.0
Fiscal Year Mar, 2024 Mar, 2015 Mar, 2015 Mar, 2015 Mar, 2024
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 5,408 1,192 1,175 813 95.7 60 May 11, 2022 J-GAAP
Oct - Mar, 2022 5,595 1,203 1,214 841 99.7 60 May 10, 2023 J-GAAP
Oct - Mar, 2023 6,227 1,317 1,337 972 124.7 68 May 9, 2024 J-GAAP
Oct - Mar, 2024 Guidance 5,884 1,096 1,102 749 108.1 68 Nov 7, 2024 J-GAAP
YoY -5.5% -16.8% -17.6% -22.9% -13.4%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2022 1,861 4,551 2,062 2,489 -598 11,523 62.26 J-GAAP
Mar, 2023 1,649 732 887 -155 -505 11,750 60.43 J-GAAP
Mar, 2024 1,840 1,042 1,142 -100 -4,205 8,586 49.25 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 3,772 446 454 309 36.7 27.2 Nov 4, 2022 J-GAAP
Apr - Sep, 2023 4,056 523 533 376 46.2 28.5 Nov 7, 2023 J-GAAP
Apr - Sep, 2024 4,116 304 298 221 32.1 21.3 Nov 7, 2024 J-GAAP
YoY +1.5% -41.9% -44.1% -41.2% -30.5%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 2,289 377 375 254 30.2 16.5 Feb 1, 2023 J-GAAP
Jan - Mar, 2023 3,306 826 839 587 69.6 25.0 May 10, 2023 J-GAAP
Apr - Jun, 2023 1,770 81 91 72 8.8 4.6 Aug 2, 2023 J-GAAP
Jul - Sep, 2023 2,286 442 442 304 37.3 19.3 Nov 7, 2023 J-GAAP
Oct - Dec, 2023 2,368 405 404 270 33.5 17.1 Feb 7, 2024 J-GAAP
Jan - Mar, 2024 3,859 912 933 702 90.1 23.6 May 9, 2024 J-GAAP
Apr - Jun, 2024 1,999 250 255 173 25.1 12.5 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 2,117 54 43 48 7.0 2.6 Nov 7, 2024 J-GAAP
YoY -7.4% -87.8% -90.3% -84.2% -81.4%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 3,859 994 954 702 90.1
Fiscal Year Mar, 2024 Mar, 2015 Mar, 2015 Mar, 2024 Mar, 2024
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2022 1,858.63 84.6 18,508 15,650 14,260 May 11, 2022 J-GAAP
Mar, 2023 1,933.89 84.3 19,443 16,386 14,890 May 10, 2023 J-GAAP
Mar, 2024 1,998.92 79.3 17,433 13,818 15,730 May 9, 2024 J-GAAP
Apr - Sep, 2024 82.5 16,490 13,606 15,482 Nov 7, 2024 J-GAAP